The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,080.00
Bid: 12,078.00
Ask: 12,080.00
Change: 30.00 (0.25%)
Spread: 2.00 (0.017%)
Open: 11,966.00
High: 12,124.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Rolls-Royce Up On Huge Emirates Order

Fri, 17th Apr 2015 10:20

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Friday.
-------
FTSE 100 WINNERS
-------
Rolls-Royce Holdings, up 1.3%. The jet engine and power turbine company confirmed it has won its largest ever order, worth USD9.2 billion, to provide engines and support services to Emirates for 50 Airbus A380 aircraft, a deal that breaks the stranglehold that a rival engine maker had on providing engines for the airline's fleet of superjumbo aircraft. Under the deal, the British company will provide Trent 900 engines and TotalCare service support to Emirates, with the engines to power 50 Airbus A380 aircraft due to enter service in 2016.

Pearson, up 1.4%. The educational and publishing group shares are higher after closing as the biggest faller on Thursday on a Wall Street Journal report Wednesday that the Los Angeles school district is to end its use of content provided by Pearson under the Common Core Technology Project.

Whitbread, up 0.6% at 5,256.63 pence. Credit Suisse lifted its price target for the hotel and coffee-shop operator to 6,200 pence from 5,300p, reiterating its Outperform recommendation.

Astrazeneca, up 0.6%. The pharmaceutical giant said the US Food and Drug Administration has granted orphan drug designation for its selumetinib treatment for uveal melanoma, and that the latest data from its ongoing trial of AZD9291 in non-small cell lung cancer shows a delay in disease progression. Separately, Deutsche Bank lifted the company's price target to 4,850 from 4,800, keeping its Hold rating.
-------
FTSE 100 LOSERS
-------
GKN, down 0.5% at 368.8p. Exane BNP downgraded the engineering group to Neutral from Outperform, with a price target of 380p.
-------
FTSE 250 WINNERS
-------
Hunting, up 5.8% at 636.00p. Goldman Sachs upgraded the energy services company to Conviction Buy from Buy, lifting its price target to 709p from 622p.

Qinetiq Group, up 4.8% at 204.5p. Barclays upgraded the defence services company to Overweight from Equal Weight, lifting its price target to 220p from 210p, while Goldman Sachs has slightly raised the company's price target to 208p from 204, reiterating its Hold recommendation.

Debenhams, up 4.3% at 88.57p, having hit a new 16-month high of 89.00p. Several brokers updated their stances on the department store. Citigroup upgraded Debenhams to Buy from Neutral, lifting its price target to 95p from 75p, while SocGen raised the company's price target to 80p from 67p, keeping its Hold rating. Meanwhile, UBS raised its price target to 90p from 85p, reiterating its Buy recommendation. The upgrades come after Debenhams reported a rise in profit for the first half of its financial year, with its shares touching a 15-month high Thursday.
-------
FTSE 250 LOSERS
-------
Indivior, down 2.0% at 208.90p. Deutsche Bank downgraded the former pharmaceutical division of Reckitt Benckiser to Hold from Buy, but lifted its price target to 212p from 180p.
-------
AIM ALL-SHARE WINNERS
-------
Applied Graphene Materials, up 16%. The speciality graphene materials provider said it has received positive preliminary results from independent performance testing conducted on graphene-reinforced polyurethane coatings using graphene it produced. The initial results demonstrate low loading levels of its graphene nanoplatelets substantially enhance the scratch resistance and ultimate tensile strength of a polyurethane clearcoat with minimal damage to transparency or colour, it said.

Zamano, up 10%. The Irish mobile payments and marketing company said it is now an approved direct carrier billing partner for Three Ireland. It said the connection covers all of Three's customers including those obtained during the recent acquisition of O2. Three represents approximately 36% of the mobile market in Ireland according to latest figures, it said.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.